Spear Bio Co-Founder Feng Xuan to Present at Vaccines Summit this Month in Boston.

Keywords: Antibodies; Biological Products; Blood Proteins; COVID-19; Coronavirus; Health and Medicine; Immunization; Immunoglobulins; Immunology; Immunoproteins; Neutralizing Antibodies; Proteins; RNA Viruses; SARS-CoV-2; Severe Acute Respiratory Syndrome Coronavirus 2; Spear Bio; Vaccines; Viral; Virology EN Antibodies Biological Products Blood Proteins COVID-19 Coronavirus Health and Medicine Immunization Immunoglobulins Immunology Immunoproteins Neutralizing Antibodies Proteins RNA Viruses SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2 Spear Bio Vaccines Viral Virology 768 768 1 05/29/23 20230529 NES 230529 2023 JUN 2 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Spear Bio co-founder, President & CTO, Feng Xuan, Ph.D. will be presenting at the upcoming Vaccines Summit (#VSBoston, May 22-24) at the Boston Marriott Newton Hotel. Keywords for this news article include: Viral, COVID-19, Vaccines, Virology, Spear Bio, Immunology, SARS-CoV-2, RNA Viruses, Immunization, Blood Proteins, Immunoproteins, Immunoglobulins, Biological Products, Health and Medicine, Neutralizing Antibodies, Severe Acute Respiratory Syndrome Coronavirus 2. Dr. Feng Xuan's presentation - A novel ultrasensitive cell-free SARS-CoV-2 neutralizing antibody assay for measuring humoral immune response of vaccine with high lab-to-lab consistency - will be part of the COVID-19 Vaccine R&D session. [Extracted from the article]